Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4

ABSTRACT: Primary Objective: Correlation of the skin and/or eye toxicity grade secondary to Cetuximab or Panitumumab and the SNP profile of the Epidermal Growth Factor Receptor (EGFR) domain III region. Secondary Objectives: Correlation of SNP profile with indicators of tumour response parameters, such as radiological response, duration of response, time to progression (TTP), overall survival (OS) time, incidence of non-dermatological adverse events.

DISEASE(S): Non-small Cell Lung Cancer,Colorectal Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung

PROVIDER: 2135070 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR